Plantar fasciitis is one of the most common conditions encountered by a podiatric physician. Although most individuals respond well to traditional conservative and surgical remedies, a portion of patients will exhaust all available treatment options and will experience ongoing pain that can ultimately affect their quality of life. There has been an increase in scientific and clinical research surrounding the medical use of human placental membranes (HPMs) and many of these point-of-care allografts are now commercially available. We present the case of a 53-year-old female with chronic plantar fasciitis for whom both conservative therapies and surgical treatments of 1 year's duration had previously failed. After open revision with implantation of viable intact cryopreserved human placental membrane (vCPM; Grafix, Osiris Therapeutics, Inc., Columbia, MD), the patient was able to resume her full-work duty with minimal symptoms at the 12- and 24-month follow-up examinations. This case report highlights the use of HPMs as an adjunct approach in the treatment of recalcitrant plantar fasciitis and the need for continued research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.jfas.2017.09.007 | DOI Listing |
J Foot Ankle Surg
December 2024
Fellowship-Trained, Board Certified Foot and Ankle Surgeon; Orthopedic Foot and Ankle Center, 350 W. Wilson Bridge Rd, Ste. 200, Worthington, OH 43085.
BMC Musculoskelet Disord
December 2024
Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway.
Background: Plantar fasciopathy is common, is characterized by heel pain and is associated with decreased functioning and health-related quality of life. While many recover from this condition, a considerable number of people experience persistent heel pain. This study seeks to evaluate predictors for pain and function twelve months after inclusion in a treatment trial in specialist care.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Rehabilitation Medicine, Zibo Central Hospital, Zibo, Shandong, China.
Objective: The purpose of this meta-analysis was to evaluate the therapeutic efficacy and safety of botulinum toxin A (BTA) injections for treatment of plantar fasciitis (PF).
Methods: This review adhered to the PRISMA guidelines, conducting a comprehensive search of the PubMed, Web of Science, EMBASE, and Cochrane Library databases for eligible studies from their inception to December 30 2023. The inclusion criteria were limited to randomized controlled trials (RCTs) comparing BTA injections with control interventions in terms of pain reduction, functional improvement, or the occurrence of adverse events in treating patients with PF were extracted for meta-analysis.
J Clin Med
November 2024
Department of Orthopedics, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
: Degenerative cervical myelopathy is a progressive neurological disorder that is commonly encountered in clinical practice and its incidence is expected to increase alongside the aging population. Given the importance of early and accurate diagnosis in this patient population, this narrative review aims to provide a repository of up-to-date information regarding pertinent patient history, physical exam findings, and potential alternate diagnoses. : The PubMed database was queried for publications from 1 January 2019 to 19 March 2024.
View Article and Find Full Text PDFJ Foot Ankle Res
December 2024
Discipline of Podiatry, School of Allied Health, Human Services and Sport, La Trobe University, Bundoora, Victoria, Australia.
Background: The visual analogue scale (VAS) and the Foot Health Status Questionnaire (FHSQ) are patient-reported outcome measures that are frequently used to evaluate the management of plantar heel pain. This study aimed to re-calculate (i.e.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!